US Probes Merck's Marketing Of 3 Drugs
By Bibeka Shrestha ( August 8, 2011, 8:41 PM EDT) -- Merck & Co. Inc. disclosed Monday that the U.S. Department of Justice had asked it to turn over documents detailing marketing practices for cancer drugs Temodar and Intron A and hepatitis C drug PegIntron as part of a criminal investigation....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.